Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Follow-up of Sollentuna Prevention Program (SoPP)

19. januar 2015 opdateret af: Mai-Lis Hellénius, Professor, Karolinska Institutet

Long-term Follow-up of an Individual and Population-based Program Aimed at Preventing Cardiovascular Disease in Sollentuna Municipality

To evaluate long-term effects of one individual- and population-oriented cardiovascular prevention programs in primary care.

Studieoversigt

Status

Ukendt

Betingelser

Detaljeret beskrivelse

In Sweden there are unique opportunities to create a relevant comparison group for this study, which is of great importance to the value of this cohort study.

Of the three study populations two (2-3)will be created by using national registries.

  1. The screened group consists of the individuals (n = 5938) who had direct contact with the prevention program, ie undergone a voluntary opportunistic cardiovascular screening (questionnaire, physical examination and testing in connection with visits to health centers) and the rest of all individuals who lived in Sollentuna Municipality between 1988-1993.
  2. Relatives of individuals included in the screened group who lived in Stockholm county at the time of the intervention will be identified by the use of the Medical Birth Register and the Multi-Generation Register. Family members are defined as parents, siblings and children and husband / wife to those in thescreened group and will be analyzed in the same way as those who participated in the intervention for risk of developing cardiovascular disease and cancer.
  3. The comparison group consists of the entire population of Stockholm County minus Sollentuna 1988-93, taking into account population changes (migration, birth, death) during the period.

This three populations will be followed-up in national registries and databases

All subjects will be monitored for example disease history, socio-economics and biochemical risk factors presented below national registries and research databases. When all the matches of national registers and a local register (AMORIS)have been done the database will de-identified and anonymized data to be available for statistical processing.

Undersøgelsestype

Observationel

Tilmelding (Forventet)

1600000

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

15 år og ældre (Barn, Voksen, Ældre voksen)

Tager imod sunde frivillige

Ja

Køn, der er berettiget til at studere

Alle

Prøveudtagningsmetode

Ikke-sandsynlighedsprøve

Studiebefolkning

  1. The screened group who participated in the cardiovascular prevention program:

    (n=5938) and the rest of the population in Sollentuna Municipality.

  2. To the screened group matched "controls" will be selected randomly from the population of Stockholm County minus Sollentuna. The population in Sollentuna will compared to the population of Stockholm County minus Sollentuna Municipality.
  3. Relatives of individuals included in the intervention group and who lived in Stockholm County at the time of the intervention will be identified by use of national registers.

Beskrivelse

Inclusion Criteria in the risk intervention group:

  • Individuals 15 years of age or more who visited three (four) health care centres in Sollentuna 1988-1993 were offered to participate in the prevention program

Exclusion Criteria in the screened intervention group:

  • Age < 15 years

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

Kohorter og interventioner

Gruppe / kohorte
Screened group
Screened group is defined as those individuals who were willing to participate in the cardiovascular prevention program and all the individuals who lived in Sollentuna during the intervention.
Relatives to the screened group
Relatives to individuals included in the screened group, who lived in Stockholm County at least during one year at the time of the intervention.
Control group
Matched "controls" is going to be selected randomly from the population of Stockholm County minus Sollentuna Municipality with relevant background factors. The whole population will be used as a comparison group when evaluating the result from all the municipality of Sollentuna during 1988-1993.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Incidence and mortality in acute myocardial infarction, stroke, cardiovascular disease, and overall mortality, a twenty year follow-up of a prevention program.
Tidsramme: 24 years
Long term follow-up of a cardiovascular prevention program by using Swedish national patient registries
24 years

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
A follow-up of drug treatment of diabetes, dyslipidemia and hypertension
Tidsramme: 24 years
By using the drug register in Sweden do a follow-up of drug treatment in the cohort
24 years

Andre resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Incidence and mortality in cancer
Tidsramme: 24 years
Incidence and mortality in cancer - a twenty year follow-up by using the swedish cancer register
24 years
Consumption of medical care overall and for different diagnostic groups
Tidsramme: 24 years
To study medical care consumption overall for different diagnostic groups by using different registers in Sweden
24 years
Health economic aspects
Tidsramme: 24 years

Health economic aspects such as

  1. health care consumption in total and for different diagnostic groups
  2. care costs
  3. impact on indirect costs (lost working years and sick leave)
  4. intervention cost will be studied
24 years
Time trends of morbidity and mortality in acute myocardial infarction, stroke, cardiovascular disease and total mortality
Tidsramme: 24 years
To study time trends of morbidity and mortality in acute myocardial infarction, stroke, cardiovascular disease and total mortality by use of National Swedish registries.
24 years

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Samarbejdspartnere

Efterforskere

  • Ledende efterforsker: Gunilla Journath, PhD, Karolinska Institutet

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart

1. juni 1988

Primær færdiggørelse (Forventet)

1. september 2015

Studieafslutning (Forventet)

1. december 2016

Datoer for studieregistrering

Først indsendt

7. august 2014

Først indsendt, der opfyldte QC-kriterier

7. august 2014

Først opslået (Skøn)

8. august 2014

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Skøn)

21. januar 2015

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

19. januar 2015

Sidst verificeret

1. januar 2015

Mere information

Begreber relateret til denne undersøgelse

Yderligere relevante MeSH-vilkår

Andre undersøgelses-id-numre

  • 20100473
  • 2012/1172-31/1 (Anden identifikator: Regional Ethical Review Board, Stockholm)

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med Hjerte-kar-sygdomme

Abonner